LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Operating Expenses | 7,046 | 10,015 | 13,721 | 13,430 | 11,104 |
| Operating Income | -7,046 | -10,015 | -13,721 | -13,430 | -11,104 |
| Interest Expense | 0 | 0 | 0 | 29 | 7 |
| Other Income | 112 | 92 | 180 | 300 | 425 |
| Pre-tax Income | -6,934 | -9,923 | -13,541 | -13,159 | -10,686 |
| Net Income Continuous | -6,934 | -9,923 | -13,541 | -13,159 | -10,686 |
| Net Income | $-6,934 | $-9,923 | $-13,541 | $-13,159 | $-10,686 |
| EPS Basic Total Ops | -0.15 | -0.23 | -0.32 | -0.31 | -0.25 |
| EPS Basic Continuous Ops | -0.15 | -0.23 | -0.32 | -0.31 | -0.25 |
| EPS Diluted Total Ops | -0.15 | -0.23 | -0.32 | -0.31 | -0.25 |
| EPS Diluted Continuous Ops | -0.15 | -0.23 | -0.32 | -0.31 | -0.25 |
| EBITDA(a) | $-6,551 | $-9,505 | $-13,201 | $-12,968 | $-10,857 |